EconPapers    
Economics at your fingertips  
 

Unravelling hepatitis C virus replication from genome to function

Brett D. Lindenbach and Charles M. Rice ()
Additional contact information
Brett D. Lindenbach: Center for the Study of Hepatitis C, The Rockefeller University
Charles M. Rice: Center for the Study of Hepatitis C, The Rockefeller University

Nature, 2005, vol. 436, issue 7053, 933-938

Abstract: Abstract Since the discovery of the hepatitis C virus over 15 years ago, scientists have raced to develop diagnostics, study the virus and find new therapies. Yet virtually every attempt to dissect this pathogen has met with roadblocks that impeded progress. Its replication was restricted to humans or experimentally infected chimpanzees, and efficient growth of the virus in cell culture failed until very recently. Nevertheless hard-fought progress has been made and the first wave of antiviral drugs is entering clinical trials.

Date: 2005
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://www.nature.com/articles/nature04077 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:436:y:2005:i:7053:d:10.1038_nature04077

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature04077

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:nature:v:436:y:2005:i:7053:d:10.1038_nature04077